The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
about
Nanoparticles: health effects - pros and consNanocarriers Usage for Drug Delivery in Cancer TherapyRecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingCombating pathogenic microorganisms using plant-derived antimicrobials: a minireview of the mechanistic basisPrevention and treatment of biofilms by hybrid- and nanotechnologies.ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coliIsoxyl aerosols for tuberculosis treatment: preparation and characterization of particlesToxicology and drug delivery by cucurbit[n]uril type molecular containersEffects of Ultrasound Irradiation on the Release Profile of 5-fluorouracil from Magnetic Polylactic co-glycolic Acid Nanocapsules.Polymeric Nanostructures for Imaging and TherapyEnhanced pharmacological activity of vitamin B₁₂ and penicillin as nanoparticles.One-step electrohydrodynamic production of drug-loaded micro- and nanoparticlesPreparation and evaluation of gelatin/sodium carboxymethyl cellulose polyelectrolyte complex microparticles for controlled delivery of isoniazid.Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeuticsCytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristicsTargeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemiaDevelopment and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design.PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway.Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics.Analysis of the in vivo and in vitro effects of photodynamic therapy on breast cancer by using a sensitizer, sinoporphyrin sodium.Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme.Rifapentine-proliposomes for inhalation: in vitro and in vivo toxicity.Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.Current development and future prospects in chemotherapy of tuberculosisMultilayer Coating of Tetrandrine-loaded PLGA nanoparticles: Effect of surface charges on cellular uptake rate and drug release profile.Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticlesCodelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis.Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance.Synthesis and Characterization of L-Lysine Conjugated Silver Nanoparticles Smaller Than 10 nM.Nanotechnology-based approaches in anticancer researchTwo-step nanoprecipitation for the production of protein-loaded PLGA nanospheresCytotoxic Activities of Silver Nanoparticles and Silver Ions in Parent and Tamoxifen-Resistant T47D Human Breast Cancer Cells and Their Combination Effects with Tamoxifen against Resistant Cells.Glycosylation improves α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic)acid microspheresPreparation of Chitosan and Water-Soluble Chitosan Microspheres via Spray-Drying Method to Lower Blood Lipids in Rats Fed with High-Fat Diets.Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.Toxicity of CdSe Nanoparticles in Caco-2 Cell Cultures.Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Uses of nanoparticles for central nervous system imaging and therapy.Control of Biofilm Formation: Antibiotics and Beyond.Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging.
P2860
Q23918086-B6BFD058-AFD4-4F30-90F7-5B030FB6B125Q26740048-22F1B943-0F43-40B8-AE00-113C06C9AB8AQ26778234-7B624443-1E63-48BF-AEC5-7ACC5BDA07E7Q26851551-9F03D919-D668-41EC-A572-573EE4C5F419Q27692708-1E50A224-D60E-4CB3-B349-F3990FFA2104Q28275835-C7AAA789-1212-4B03-A2A0-75566B0CC218Q28396917-C1116804-34E4-400A-B5DF-BD412C033F11Q28473864-6B3BF578-2401-4ACD-B4F8-8CF2B6519585Q30369768-2350ECDB-9E07-4D79-9B1F-FC3FA7399539Q30372383-DDC19F11-33D4-4C90-AC1B-49CECD6F029FQ30410726-565A93F6-6E58-4874-A1CC-6E18DDEFAD6BQ30475929-6C5DE8D9-2204-4A12-8A8A-A10EF8744A70Q30915887-ABDB91B6-FFBB-447E-8E3D-1A5310C7251DQ33583948-78D876C4-1315-43A1-9BAA-BEAA95FB0FC5Q34251855-9B29E49A-8CAE-4551-B0C2-C35AAC907F6BQ34360352-BF964099-BC33-4CE0-BFD3-6507644CDA08Q34784654-D7746129-76BF-4146-A551-817364C57B52Q34986138-F027BE5B-B3DE-4232-BCDE-4B1B85048BA6Q35068522-8BFCFA0B-8E21-4BEB-AE36-D1A3851014EDQ35476065-AE1C8B56-14F5-4E78-9B68-BCF9E3F80036Q35524404-89C7C54F-23EB-4B13-A1ED-4B1CF379F1F1Q35549569-2F290D57-6D43-4E27-9789-393C197ED438Q35579500-D40848D0-5F88-49F2-B3D4-0572990638F5Q35705874-8809EEEA-557F-478F-8B33-2997788B59E7Q35912653-7F121E53-5905-4BE8-9CF3-7B7844568AA0Q35941391-6B17154B-59E4-443B-B956-82DE3E9CC367Q35991005-480FE4EC-495C-4823-AE47-401B30AC78EAQ36057394-C740D5BB-E64D-4930-A3F9-A0E93208333CQ36165525-738A0892-9FDD-446B-AF3A-FD8AB99AB2A9Q36168983-ED7832A4-519E-4E27-BD64-10D509A3F387Q36522361-657C7A77-D045-4278-B2AB-7A17B243FF67Q36571327-16BC8ED2-5BB2-4535-8C0A-68C654D31709Q36610259-9307A376-539A-4C0D-B449-AA96CE30B72EQ36656207-E9040D32-AFC6-41CA-BBA3-04198B9AB60AQ36869824-F84D7AAB-25EB-4134-8643-F44519597ED2Q36975202-F343817E-0CAF-427E-8DCB-2374485BBC0EQ37467770-44720201-1F9F-4D4D-9B50-5911E0BF3D6FQ37555829-D9D038FA-2E51-4B51-B8DB-AC89797902E4Q37593127-5FFD8B66-18F7-49B0-8009-6C89155358C6Q37770188-41AB5CD4-EBB5-41D6-8D56-8419FAFF6022
P2860
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The potential advantages of na ...... chemotherapy of tuberculosis.
@ast
The potential advantages of na ...... chemotherapy of tuberculosis.
@en
type
label
The potential advantages of na ...... chemotherapy of tuberculosis.
@ast
The potential advantages of na ...... chemotherapy of tuberculosis.
@en
prefLabel
The potential advantages of na ...... chemotherapy of tuberculosis.
@ast
The potential advantages of na ...... chemotherapy of tuberculosis.
@en
P2093
P2860
P921
P1476
The potential advantages of na ...... chemotherapy of tuberculosis.
@en
P2093
Kevin Kisich
Leonid Heifets
Michael D Iseman
Svetlana Gelperina
P2860
P304
P356
10.1164/RCCM.200504-613PP
P407
P577
2005-09-08T00:00:00Z